SEVERE PROTEINURIA DUE TO IDIOPATHIC MEMBRANOUS NEPHROPATHY

Clinical trials for SEVERE PROTEINURIA DUE TO IDIOPATHIC MEMBRANOUS NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new SEVERE PROTEINURIA DUE TO IDIOPATHIC MEMBRANOUS NEPHROPATHY trials appear

Sign up with your email to follow new studies for SEVERE PROTEINURIA DUE TO IDIOPATHIC MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to plug kidney leak in rare disease

Disease control Recruiting now

This study is testing an investigational drug called AP1189 to see if it can help control a rare kidney disease. It will involve about 23 adults who have this disease and are already on standard blood pressure medications. The main goal is to see if adding AP1189 for 12 weeks is …

Matched conditions: SEVERE PROTEINURIA DUE TO IDIOPATHIC MEMBRANOUS NEPHROPATHY

Phase: PHASE2 • Sponsor: SynAct Pharma Aps • Aim: Disease control

Last updated Mar 27, 2026 12:37 UTC

SEVERE PROTEINURIA DUE TO IDIOPATHIC MEMBRANOUS NEPHROPATHY

Get alerted when new SEVERE PROTEINURIA DUE TO IDIOPATHIC MEMBRANOUS NEPHROPATHY trials appear

New drug aims to plug kidney leak in rare disease